Pastor JC - Search Results

1

A propensity score matching application: indications and results of adding scleral buckle to vitrectomy: The Retina 1 Project: Report 3.

Sanabria MR, Fernández I, Sala-Puigdollers A, Rojas J, Alfaiate M, Elizalde J, Navea A, Cordoves L, Ruiz-Miguel M, Diaz-Llopis M, Coco RM, De La Rúa ER, Pastor JC. Sanabria MR, et al. Among authors: pastor jc. Eur J Ophthalmol. 2012 Mar-Apr;22(2):244-53. doi: 10.5301/EJO.2011.6528. Eur J Ophthalmol. 2012. PMID: 21484754

2

Value of logistic discriminant analysis for interpreting initial visual field defects.

Antón A, Maquet JA, Mayo A, Tapia J, Pastor JC. Antón A, et al. Among authors: pastor jc. Ophthalmology. 1997 Mar;104(3):525-31. doi: 10.1016/s0161-6420(97)30280-2. Ophthalmology. 1997. PMID: 9082284

3

Proliferative vitreoretinopathy: an overview.

Pastor JC. Pastor JC. Surv Ophthalmol. 1998 Jul-Aug;43(1):3-18. doi: 10.1016/s0039-6257(98)00023-x. Surv Ophthalmol. 1998. PMID: 9716190 Review.

4

Clinical consequences of the use of highly purified silicone oil. Comparative study of highly and less purified silicone oil.

Pastor JC, Zarco JM, Del Nozal MJ, Pampliega A, Marinero P. Pastor JC, et al. Eur J Ophthalmol. 1998 Jul-Sep;8(3):179-83. doi: 10.1177/112067219800800311. Eur J Ophthalmol. 1998. PMID: 9793773

5

Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes.

Coco RM, López MI, Pastor JC, Nozal MJ. Coco RM, et al. Among authors: pastor jc. J Ocul Pharmacol Ther. 1998 Dec;14(6):555-63. doi: 10.1089/jop.1998.14.555. J Ocul Pharmacol Ther. 1998. PMID: 9867338

6

Pharmacokinetics of 0.5 mg of a single and a multiple dose of intravitreal vancomycin in infected rabbit eyes.

Coco RM, Lopez MI, Pastor JC. Coco RM, et al. Among authors: pastor jc. J Ocul Pharmacol Ther. 2000 Aug;16(4):373-81. doi: 10.1089/jop.2000.16.373. J Ocul Pharmacol Ther. 2000. PMID: 10977133

7

Proliferative vitreoretinopathy: risk factors and pathobiology.

Pastor JC, de la Rúa ER, Martín F. Pastor JC, et al. Prog Retin Eye Res. 2002 Jan;21(1):127-44. doi: 10.1016/s1350-9462(01)00023-4. Prog Retin Eye Res. 2002. PMID: 11906814 Review.

8

[Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study].

Rodríguez de la Rúa E, Martínez V, Aragón J, Sanabria RM, Giraldo A, Mayo A, Pastor JC, Miranda I, García Arumí J. Rodríguez de la Rúa E, et al. Among authors: pastor jc. Arch Soc Esp Oftalmol. 2003 Feb;78(2):91-7. Arch Soc Esp Oftalmol. 2003. PMID: 12647249 Spanish.

9

Proliferative vitreoretinopathy: cytologic findings in vitreous samples.

Martín F, Pastor JC, De La Rúa ER, Mayo-Iscar A, García-Arumí J, Martínez V, Fernández N, Saornil MA. Martín F, et al. Among authors: pastor jc. Ophthalmic Res. 2003 Jul-Aug;35(4):232-8. doi: 10.1159/000071175. Ophthalmic Res. 2003. PMID: 12815199

10

[Retinal shortening: the most severe form of proliferative vitreoretinopathy (PVR)].

Pastor JC, Rodríguez de la Rúa E, Martín F, Mayo-Iscar A, de la Fuente MA, Coco R, Bailez C, Mahave S. Pastor JC, et al. Arch Soc Esp Oftalmol. 2003 Dec;78(12):653-7. Arch Soc Esp Oftalmol. 2003. PMID: 14689321 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters